Edwin Rock
Hoofd Techniek/Wetenschap/O&O bij GLYCOMIMETICS, INC.
Vermogen: 184 389 $ op 31-05-2024
Profiel
Edwin P.
Rock is currently the Chief Medical Officer & Senior Vice President at GlycoMimetics, Inc. Prior to his current position, he served as the Chief Medical Officer at Partner Therapeutics, Inc. Dr. Rock completed his undergraduate degree at Swarthmore College and obtained his doctorate from Stanford University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GLYCOMIMETICS, INC.
1.06% | 21-06-2024 | 680 403 ( 1.06% ) | 184 389 $ | 31-05-2024 |
Actieve functies van Edwin Rock
| Bedrijven | Functie | Begin |
|---|---|---|
| GLYCOMIMETICS, INC. | Hoofd Techniek/Wetenschap/O&O | 06-09-2022 |
Eerdere bekende functies van Edwin Rock
| Bedrijven | Functie | Einde |
|---|---|---|
Partner Therapeutics, Inc.
 Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Edwin Rock
| Swarthmore College | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Partner Therapeutics, Inc.
Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Health Technology |
